Image Credit: National Cancer Institute

The New Treatment Innovation Grant supports Australian researchers in developing early-stage, innovative ideas to improve pancreatic cancer treatments, diagnostics, and care quality, with a focus on generating preliminary data, answering key feasibility questions, and accelerating research translations.

This Grant will provide funding to Australian researchers who:

• Carry out projects at an early stage that will accelerate innovation of treatments, diagnostics or quality (including standard of care) to pancreatic cancer patients

• Support innovative ideas that have the potential to impact treatment or diagnostics, but may not have extensive preliminary supporting data

• Answer key feasibility and proof-of-concept questions and arrive at critical project inflection points in an accelerated time frame

• Support established and/or early career researchers to develop preliminary data and attract additional funding in subsequent years

• Accelerate research translation

Funding Criteria:

• Applications should demonstrate solid rationale and extensive planning

• Proof-of-concept or exploratory data to demonstrate the feasibility and rationale and your research question should be detailed sufficiently

• Applicants must disclose any potential overlap with other current or pending research funding

• Where applications have multiple AI’s, the role of each co-investigator must be outlined and justified

• Only one application per institution may be submitted for each scheme

• International collaborations are encouraged if the PI is located in Australia